IIa clinical

Related by string. * IIAS . IIA : Phase IIa clinical trials . Phase IIa . Phase IIa trial . initiate Phase IIa / clinicals . CLINICAL . Clinicals : Phase III clinical trials . placebo controlled clinical trials . Phase III clinical * IIa clinical trial . Phase IIa Clinical Trial . Phase IIa clinical . phase IIa clinical . Phase Ib IIa clinical . IIa clinical trials . IIa Clinical Trial *

Related by context. Frequent words. (Click for all words.) 69 phase IIa 68 phase IIb 66 Phase 1a 66 Phase Ib 65 Pivotal Phase III 65 IIa clinical trial 64 Phase 1b clinical 64 confirmatory Phase III 64 Phase IIa trial 64 Phase 2a trial 63 Phase 2b clinical 63 Phase Ia 63 Phase 1b trial 63 Phase IIa clinical 63 dose escalation trial 63 Phase 1b 63 Phase 2b study 63 Phase IIb 62 Phase III Clinical Trial 62 Phase 2a clinical 62 Pivotal Phase 62 Phase IIb trial 62 Phase IIb clinical 62 Phase 2b trial 62 registrational trial 61 Pivotal Trial 61 clinical trial 61 Phase III clinical 61 preclinical toxicology 61 KNS # 61 Allovectin 7 R 61 IND enabling 60 Phase IIa 60 PREOS 60 registrational 60 Clinical Study 60 Azedra 60 Clinical Trial Results 60 Clinical Trial 60 double blinded placebo 60 Multicenter 60 Cloretazine R VNP#M 60 multiple ascending dose 60 single ascending dose 60 NSABP 60 Phase III 60 HVTN 59 randomized Phase III 59 Initiates Phase 59 TELCYTA 59 placebo controlled clinical 59 Phase 2a 59 celgosivir 59 CR# vcMMAE 59 pivotal Phase III 59 tanespimycin 59 IND submission 59 Phase III pivotal 59 clinical trials 59 Diamyd ® 59 Phase III Trial 59 Phase 2b 59 blinded placebo controlled 59 Phase IIa clinical trials 58 Cethromycin 58 adecatumumab 58 thymalfasin 58 glufosfamide 58 Phase II 58 Phase III clinical trials 58 Sym# 58 IIa 58 diabetic neuropathic pain 58 Ofatumumab 58 Valortim 58 Completes Enrollment 58 Phenoptin 58 HuMax CD# 58 Phase 58 6R BH4 58 unblinding 58 confirmatory Phase 3 58 safety tolerability pharmacokinetics 57 RGB # 57 dose escalation study 57 multicenter clinical 57 placebo controlled randomized 57 relapsed refractory multiple myeloma 57 BCX# 57 PEG Interferon lambda 57 Carfilzomib 57 pertuzumab 57 Clevudine 57 orally bioavailable 57 CoFactor 57 Anturol 57 AVN# [001] 57 axitinib 57 DAVANAT 57 Anthim 57 preclinical

Back to home page